Oral and gastrointestinal mucositis is a toxicity of many forms of radiotherapy and
chemotherapy. It has a significant impact on health, quality of life and economic outcomes …

Mucositis induced by antineoplastic drugs is an important, dose-limiting and costly side
effect of cancer therapy. The ulcerative lesions which result are frequent systemic portals of …

Background Oral mucositis is a complication of intensive chemotherapy and radiotherapy
with no effective treatment. We tested the ability of palifermin (recombinant human …

Background Objective was to determine whether prophylactic low level laser therapy (LLLT)
reduces the risk of severe mucositis as compared to placebo or no therapy. Methods …

Chemotherapy‐and radiotherapy‐induced oral mucositis represents a therapeutic challenge
frequently encountered in cancer patients. This side effect causes significant morbidity and …

In recent years, significant improvements have been made in the management of
neutropenia and thrombocytopenia and other potentially life-threatening complications of …

Mucositis induced by antineoplastic drugs is an important, dose-limiting, and costly side
effect of cancer therapy. The ulcerative lesions produced by mucotoxic chemoradiotherapy …

Oral mucositis remains one of the most common and troubling side effects of standard
chemoradiation regimens used for the treatment of head and neck cancer. Virtually all …

A multitude of laboratory and clinical research studies of ulcerative oral mucositis induced by
cytotoxic cancer therapies have been reported during the past decade. However, a …

Oral mucositis (OM) has emerged as a common cause of dose delays and interruptions of
cancer therapies such as multicycle chemotherapy, myeloablative chemotherapy, and …